yyy60 on the IV MB:
>>** It will be the 5th CK in NY, the 2nd in Long Island **
Cyberknife of Long Island
Advanced Tumor Treatment - Cyberknife Coming to Suffolk County, Long Island
September 2009
Cyberknife of Long Island, part of North Shore Radiation Therapy is proud to offer a ground-breaking cancer treatment - the CyberKnife® Robotic Radiosurgery System. The CyberKnife is the world’s first and only radiosurgery system designed to pinpoint and destroy tumors in the body. In many cases, the treatment offers new hope to patients who were considered untreatable or inoperable, who may be looking for an alternative to surgery, or who have recieved radiation therapy in the past, but still require further treatment
Saturday, June 20, 2009
What Happens at SIFMA Stays at SIFMA
from Insidemarketdata.com. SIFMA Technology Management Conference and Exhibit:
>>What Happens at SIFMA Stays at SIFMA
Algorithmic trading and low latency remain high priorities, so it's not surprising that many SIFMA exhibitors are capitalizing on low-latency solutions for processing and distributing direct exchange feeds and other market data. From Activ to Aleri, Exegy to Equinix, and Fixnetix to Correlix, vendors serving this highly competitive space are reportedly seeing more business as firms attempt to squeeze every last drop of latency out of their infrastructures and cautiously prepare for a market rebound.
>>What Happens at SIFMA Stays at SIFMA
Algorithmic trading and low latency remain high priorities, so it's not surprising that many SIFMA exhibitors are capitalizing on low-latency solutions for processing and distributing direct exchange feeds and other market data. From Activ to Aleri, Exegy to Equinix, and Fixnetix to Correlix, vendors serving this highly competitive space are reportedly seeing more business as firms attempt to squeeze every last drop of latency out of their infrastructures and cautiously prepare for a market rebound.
Friday, June 19, 2009
Research Study Will Compare Two Treatments for Lung Cancer
yyy60 on the IV MB:
>>Research Study Will Compare Two Treatments for Lung Cancer
Saint Louis University Is the Only Local Research Site to Participate In the Phase III Trial
SAINT LOUIS - Saint Louis University researchers are participating in a clinical trial comparing two standard treatments for early-stage NSCLC (Non-Small Cell Lung Cancer), the most common form of lung cancer.
The STARS (Stereotactic Radiosurgery vs. Surgery) trial will compare the three-year survival rate of patients who undergo a lobectomy, a surgical procedure to remove the tumor, versus CyberKnife treatment, a unique stereotactic body radiotherapy technique that precisely tracks and focuses the radiation on the tumor.
"Surgery is the current gold standard treatment for Stage I NSCLC. However, there are research reports that describe similar survival rates of operable patients treated with the CyberKnife," said John Dombrowski, M.D., Ph.D., assistant professor of radiation oncology at Saint Louis University School of Medicine.
"The STARS trial is a large, multicenter Phase III clinical trial that will allow us to definitively say which treatment is better for these patients."
Saint Louis University Hospital is the only local hospital to own and operate a CyberKnife and is the only medical center in the region to participate in the STARS clinical trial, which is led by M.D. Anderson Cancer Center in Houston, Texas and sponsored by Accuray Inc., which manufactures the CyberKnife.
>>Research Study Will Compare Two Treatments for Lung Cancer
Saint Louis University Is the Only Local Research Site to Participate In the Phase III Trial
SAINT LOUIS - Saint Louis University researchers are participating in a clinical trial comparing two standard treatments for early-stage NSCLC (Non-Small Cell Lung Cancer), the most common form of lung cancer.
The STARS (Stereotactic Radiosurgery vs. Surgery) trial will compare the three-year survival rate of patients who undergo a lobectomy, a surgical procedure to remove the tumor, versus CyberKnife treatment, a unique stereotactic body radiotherapy technique that precisely tracks and focuses the radiation on the tumor.
"Surgery is the current gold standard treatment for Stage I NSCLC. However, there are research reports that describe similar survival rates of operable patients treated with the CyberKnife," said John Dombrowski, M.D., Ph.D., assistant professor of radiation oncology at Saint Louis University School of Medicine.
"The STARS trial is a large, multicenter Phase III clinical trial that will allow us to definitively say which treatment is better for these patients."
Saint Louis University Hospital is the only local hospital to own and operate a CyberKnife and is the only medical center in the region to participate in the STARS clinical trial, which is led by M.D. Anderson Cancer Center in Houston, Texas and sponsored by Accuray Inc., which manufactures the CyberKnife.
FiberLight® Lights Up Baltimore Technology Park Customer Base in Northern Virginia and Metro Baltimore
FiberLight, LLC, a leading optical transport solutions provider, announced that Baltimore Technology Park (BTP) has selected FiberLight to provide secure Ethernet capacity to connect BTP’s data center with Greater Baltimore’s Business District and the Equinix Data Center Service Facility in Ashburn, VA. Equinix is considered one of the largest IP Peering locations on the East Coast.
FiberLight’s Ethernet offering will provide BTP clients with a direct, affordable, low-latency route to Equinix.
“It’s a win-win solution for Baltimore Technology Park and FiberLight,” said Mike Miller, FiberLight CEO. “Connecting BTP to downtown Baltimore and Ashburn, VA allows us to extend our footprint, while BTP benefits from FiberLight’s robust core metro network and our 24/7 network monitoring capabilities to proactively address any issues.”
VoxCAST’s Singapore POP up and humming
VoxCAST’s Singapore POP up and humming
June 15th, 2009
posted by Dr. Kris Beevers
A few weeks ago and after a lot of hard work by Voxel’s elite admins and network commandos, we finally brought VoxCAST’s Singapore POP online, nestled in the Equinix facility in Ayer Rajah a few minutes’ drive from our Singapore offices. With this, web browsers is AsiaPac will see significant improvements in load times for VoxCAST-hosted sites.
Voxel is now well-established in Singapore: our offices at Clarke Quay are starting to overflow with developers and systems engineers; our VoxCAST servers are humming; and our SilverLining cluster is up and running with hundreds of cores. (Want some compute power in Singapore? Let us know!) Adam, Voxel’s lead network commando, will have some more details of our Singapore deployment and other network happenings in an upcoming post.
And yes, we’re still in love with chicken rice.
What lies ahead for Internap's CDN?
from Tier 1 Research daily newsletter:
>>What lies ahead for Internap's CDN?
There's been no shortage of employee turnover at CDNs this year, and Internap Network Services is the latest example of that. Steve Kiene, VP of engineering at Internap, is leaving the company. Internap has seen a number of executive departures already this year, and reduced staffing in other senior management ....
>>What lies ahead for Internap's CDN?
There's been no shortage of employee turnover at CDNs this year, and Internap Network Services is the latest example of that. Steve Kiene, VP of engineering at Internap, is leaving the company. Internap has seen a number of executive departures already this year, and reduced staffing in other senior management ....
Hands on With Samsung's Android Handset
HT to dqma on the IV MB:
>>Hands on With Samsung's Android Handset
Samsung Electronics gave the world a first look at its upcoming Galaxy handset, which runs Google's Android operating system, at the CommunicAsia exhibition in Singapore, where I had a chance to try it out.
Another nice feature of the Galaxy is the haptic feedback on the touchscreen when typing on the virtual keyboard. As you type, the handset vibrates slightly to let you know when a key has been touched. This could help win over users who've avoided touchscreen handsets.
>>Hands on With Samsung's Android Handset
Samsung Electronics gave the world a first look at its upcoming Galaxy handset, which runs Google's Android operating system, at the CommunicAsia exhibition in Singapore, where I had a chance to try it out.
Another nice feature of the Galaxy is the haptic feedback on the touchscreen when typing on the virtual keyboard. As you type, the handset vibrates slightly to let you know when a key has been touched. This could help win over users who've avoided touchscreen handsets.
Thursday, June 18, 2009
A Cyberknfie comig to Elmhurst IL
from the IV MB, by yyy60:
>>Elmhurst Memorial Hospital in suburban Chicago is installing a cyberknife. It will be the 4th CK in IL. The CK center will be open for patient care in Aug 2009.
>>Elmhurst Memorial Hospital in suburban Chicago is installing a cyberknife. It will be the 4th CK in IL. The CK center will be open for patient care in Aug 2009.
| Department: | EMH Cyberknife |
Survey: Smartphone demand accelerating
from Fortune:
>>Survey: Smartphone demand accelerating
>>Survey: Smartphone demand accelerating
Demand for smartphones (as opposed to ordinary cellphones) has never been higher and continues to accelerate, according to a report issued Thursday by RBC Capital and ChangeWave Reseach.
In a note to client, RBC’s Mike Abramsky ticks off four key findings from interviews conducted June 9-15 among 4,100 mostly high-end consumers.
Touchscreens are hot. 43% of prospective smartphone buyers say touchscreens are “very important” to them, up from 33% in September. But users who do a lot of typing still prefer QWERTY keyboards (33%, basically unchanged).Wednesday, June 17, 2009
New Radiotherapy Technique Proven Safe, Less Toxic For Cancer Patients, University Of Pittsburgh Cancer Institute Study Finds
from the IV MB, by yyy60:
>>New Radiotherapy Technique Proven Safe, Less Toxic For Cancer Patients, University Of Pittsburgh Cancer Institute Study Finds
Medical News Today
Main Category: Radiology / Nuclear Medicine
Also Included In: Cancer / Oncology
Article Date: 17 Jun 2009 - 2:00 PDT
A new technique known as stereotactic body radiotherapy (SBRT) is safe for patients with recurrent head and neck cancers and may improve their quality of life, according to researchers from the University of Pittsburgh Cancer Institute (UPCI). Results of the phase I study were reported today in the International Journal of Radiation Oncology, Biology, Physics.
Each year approximately 500,000 cases of squamous cell carcinoma of the head and neck are diagnosed worldwide. While treatment has improved with advances in surgery, radiation and chemotherapy, more than half of patients will die from recurrent disease. Treatment options for patients with recurrent disease are limited, and for many, surgery may not be an option, according to principal investigator Dwight E. Heron, M.D., director, Radiation Oncology Services, UPMC Cancer Centers.
"Chemotherapy alone can provide this patient population some palliation and pain relief, but it doesn't prolong survival," said Dr. Heron. "A few patients may be able to receive additional radiation treatments, but head and neck cancers, by their very nature, develop in very delicate areas of the body, which provide significant retreatment challenges."
SBRT may offer these patients an alternative, noted Dr. Heron. "At the completion of our study, we found this treatment was tolerated very well. No maximum tolerated dose was reached, and no toxicities occurred that caused us to limit the dosing."
SBRT is a relatively new technique using CyberKnife® technology, which delivers high doses of radiation with more precision than conventional techniques. The vast majority of patients complete treatment within 10 days. In the trial, 31 patients with recurrent, inoperable head and neck cancers were treated over a two-week period. PET-CT also was used to develop an individualized radiation treatment plan for each patient, allowing radiation oncologists to more accurately target the cancer while sparing healthy tissue.
"Ultimately, SBRT offers patients a better quality of life. Instead of having to go through six or seven weeks of treatments that are often associated with significant toxicities, patients can receive treatment over a shorter course and still get the same outcomes compared to the current standard of care," said Dr. Heron.
Study co-authors include Robert L. Ferris, M.D., Ph.D., Michalis Karamousiz, M.D., Regiane S. Andrade, M.D., Erin L. Deeb, B.S., Steven Burton, M.D., William E. Gooding, M.S., Barton F. Branstetter, M.D., James M. Mountz, M.D., Ph.D., Jonas T. Johnson, M.D., Anthanassios Argiris, M.D., Jennifer R. Grandis, M.D., Stephen Y. Lai, M.D., Ph.D., all of the University of Pittsburgh Cancer Institute.
This study was funded by the University of Pittsburgh Cancer Institute.
>>New Radiotherapy Technique Proven Safe, Less Toxic For Cancer Patients, University Of Pittsburgh Cancer Institute Study Finds
Medical News Today
Main Category: Radiology / Nuclear Medicine
Also Included In: Cancer / Oncology
Article Date: 17 Jun 2009 - 2:00 PDT
A new technique known as stereotactic body radiotherapy (SBRT) is safe for patients with recurrent head and neck cancers and may improve their quality of life, according to researchers from the University of Pittsburgh Cancer Institute (UPCI). Results of the phase I study were reported today in the International Journal of Radiation Oncology, Biology, Physics.
Each year approximately 500,000 cases of squamous cell carcinoma of the head and neck are diagnosed worldwide. While treatment has improved with advances in surgery, radiation and chemotherapy, more than half of patients will die from recurrent disease. Treatment options for patients with recurrent disease are limited, and for many, surgery may not be an option, according to principal investigator Dwight E. Heron, M.D., director, Radiation Oncology Services, UPMC Cancer Centers.
"Chemotherapy alone can provide this patient population some palliation and pain relief, but it doesn't prolong survival," said Dr. Heron. "A few patients may be able to receive additional radiation treatments, but head and neck cancers, by their very nature, develop in very delicate areas of the body, which provide significant retreatment challenges."
SBRT may offer these patients an alternative, noted Dr. Heron. "At the completion of our study, we found this treatment was tolerated very well. No maximum tolerated dose was reached, and no toxicities occurred that caused us to limit the dosing."
SBRT is a relatively new technique using CyberKnife® technology, which delivers high doses of radiation with more precision than conventional techniques. The vast majority of patients complete treatment within 10 days. In the trial, 31 patients with recurrent, inoperable head and neck cancers were treated over a two-week period. PET-CT also was used to develop an individualized radiation treatment plan for each patient, allowing radiation oncologists to more accurately target the cancer while sparing healthy tissue.
"Ultimately, SBRT offers patients a better quality of life. Instead of having to go through six or seven weeks of treatments that are often associated with significant toxicities, patients can receive treatment over a shorter course and still get the same outcomes compared to the current standard of care," said Dr. Heron.
Study co-authors include Robert L. Ferris, M.D., Ph.D., Michalis Karamousiz, M.D., Regiane S. Andrade, M.D., Erin L. Deeb, B.S., Steven Burton, M.D., William E. Gooding, M.S., Barton F. Branstetter, M.D., James M. Mountz, M.D., Ph.D., Jonas T. Johnson, M.D., Anthanassios Argiris, M.D., Jennifer R. Grandis, M.D., Stephen Y. Lai, M.D., Ph.D., all of the University of Pittsburgh Cancer Institute.
This study was funded by the University of Pittsburgh Cancer Institute.
InterNAP DEN003 Down
As usual, awaiting more info, it's just a small note at this link for the time being:
>>InterNAP DEN003 Down
by admin on Jun.17, 2009, under Web Hosting Talk
Just wanted to note that InterNAP’s DEN003 PNAP is down. I know that both us and FDC are serviced via this PNAP. Our network continues
Radiosurgery for the Entire Body Reaches Birmingham
Birmingham Medical News, HT to yyy60 on the IV MB:
>>Radiosurgery for the Entire Body Reaches Birmingham
Cyberknife in Action: Patient rests comfortably under cyberknife.
>>Radiosurgery for the Entire Body Reaches Birmingham
"It is just a matter of letting physicians know that it is now available," says Swaid N. Swaid, MD, the neurosurgeon behind bringing a Cyberknife System to the area and Medical Director for the new facility. "Many of them already know the advantages it brings to their patients, but now it's here."
CyberKnife, like the Gamma Knife, uses precise, powerful beams of radiation to destroy lesions and tumors while protecting the surrounding normal tissues, reaching previously inoperable tumors. However, unlike the Gamma Knife that can only treat the cranial region, the CyberKnife "does not care where the tumors are located, it can attack them anywhere in the body," Swaid says.
In the treatment room at Cyberknife of Birmingham, the new home of this technology, the size and sleekness of the machine dominate. But when in motion, the robotic system resembles more of a graceful, abstract bird silently moving an outsized head at, what looks like, impossible angles.
Cyberknife in Action: Patient rests comfortably under cyberknife.
Tuesday, June 16, 2009
Exhibitors Make Major News at TechWeb's Enterprise 2.0 Conference
Innovation Thrives in the E2 Market With Over Two Times the Announcements at This Year's Event
API management kingpin Mashery will announce Internap has taken over managed server duties for Mashery's Premium Service customers, a result of Mashery's explosive growth in the first quarter of 2009. The company's platform powers the APIs of prominent enterprises such as Best Buy,
Internap completes 8,500-square-foot expansion in premier New York carrier hotel
from Tier 1 Research Daily newsletter:
>>Internap Network Services has recently completed a significant expansion to its colocation portfolio. In this case, when we say 'significant,' we're referring not only to the size but also to the location. The new colocation space is at its 76 9th Avenue location in New York City.
>>Internap Network Services has recently completed a significant expansion to its colocation portfolio. In this case, when we say 'significant,' we're referring not only to the size but also to the location. The new colocation space is at its 76 9th Avenue location in New York City.
Staff&Line
Madrid, 16 Junio 2009 – Staff&Line, líder europeo en soluciones para la gestión de TI, ha anunciado hoy que su producto estrella, EasyVista, una suite de software completamente integrado para la Gestión de Activos y Gestión de Servicios, está disponible en versión SaaS (Software as a Service) bajo el nombre easyVista.com.
...
EasyVista.com está instalado en una plataforma de alojamiento de Staff&Line extremadamente segura que garantiza la integridad y confidencialidad de los datos de cada empresa y que está disponible 24/7. EasyVista.com es aún más seguro y disponible que las soluciones locales. Está gestionado por profesionales de Equinix, uno de los líderes mundiales de centro de datos (www.equinix.com) con ubicaciones en Europa, Estados Unidos y Asia. Staff&Line se compromete a asegurar que EasyVista.com está disponible en un 99.9%.
...
EasyVista.com está instalado en una plataforma de alojamiento de Staff&Line extremadamente segura que garantiza la integridad y confidencialidad de los datos de cada empresa y que está disponible 24/7. EasyVista.com es aún más seguro y disponible que las soluciones locales. Está gestionado por profesionales de Equinix, uno de los líderes mundiales de centro de datos (www.equinix.com) con ubicaciones en Europa, Estados Unidos y Asia. Staff&Line se compromete a asegurar que EasyVista.com está disponible en un 99.9%.
Cancer centers add $5M radiation machines
by Nashville Business Journal, HT to yyy60 on the IV MB:
>>Cancer centers add $5M radiation machines
The area's two largest cancer centers have added state-of-the-art radiation therapy equipment that was previously unavailable in Middle Tennessee.
The CyberKnife system at Sarah Cannon is mounted on a type of robotic arm commonly used in automobile assembly plants.
>>Cancer centers add $5M radiation machines
The area's two largest cancer centers have added state-of-the-art radiation therapy equipment that was previously unavailable in Middle Tennessee.
The CyberKnife system at Sarah Cannon is mounted on a type of robotic arm commonly used in automobile assembly plants.
Monday, June 15, 2009
Equinix Chosen by NYSE Liffe to Provide Faster Market Access for Frankfurt Customers
today's P/R:
>>FRANKFURT--(BUSINESS WIRE)--Equinix, Inc., a provider of global data center services, today announced that NYSE Liffe is now offering cross-connect access from Equinix’s International Business eXchange (IBX®) data center in Frankfurt (FR2). NYSE Liffe customers based in the Equinix Frankfurt-North data center can now leverage the Secure Financial Transaction Infrastructure® (SFTI®) European network for lower latency access to the Liffe Connect global derivatives trading platform.
Back on February 2nd, we wrote:
>>Other very interesting strategic wins are being announced in Europe (this is taken from the “Winter 2008 edition of the eXchange for the Financial Sector” newsletter):
>>FRANKFURT--(BUSINESS WIRE)--Equinix, Inc., a provider of global data center services, today announced that NYSE Liffe is now offering cross-connect access from Equinix’s International Business eXchange (IBX®) data center in Frankfurt (FR2). NYSE Liffe customers based in the Equinix Frankfurt-North data center can now leverage the Secure Financial Transaction Infrastructure® (SFTI®) European network for lower latency access to the Liffe Connect global derivatives trading platform.
Back on February 2nd, we wrote:
>>Other very interesting strategic wins are being announced in Europe (this is taken from the “Winter 2008 edition of the eXchange for the Financial Sector” newsletter):
NYSE Euronext is pleased to announce its choice of Equinix as their new primary point of presence in Frankfurt. NYSE Euronext has chosen the Equinix data centre in Frankfurt as the location for their new POP in Frankfurt. The NYSE Euronext Frankfurt POP will go live in Q1 2009. In the following quarter NYSE Euronext plans to offer access to the Liffe market from the Equinix data centre via a LIFFE CONNECT gateway farm.
IP Video: King of the (Media) Word
from MediaPost:
>>Looking beyond the simplistic notion that Internet video eventually will decimate traditional media distribution, content economics can yield some surprising insights about a world that will be dominated by the Internet Bypass.
>>Looking beyond the simplistic notion that Internet video eventually will decimate traditional media distribution, content economics can yield some surprising insights about a world that will be dominated by the Internet Bypass.
Such an exercise is at the heart of a notable series of related research reports produced by Bernstein analysts Craig Moffett, Michael Nathanson, Jeffrey Lindsay and Jeff Evenson. They generally conclude that cable operators and cable networks, telcos and VOD distributors, new ad agencies and IP video equipment suppliers will be ultimate winners in the Web video game. Losers will include one-way distributors: TV stations and satellite operators. The fate of broadcast networks, TV and film studios are murky, based on how they manage paid IP access.
Subscribe to:
Posts (Atom)
Posts
